Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance.
Brenus Pharma has raised $12.6M in total funding. The most recent round was Series A. The last funding was announced in July 2026.
Brenus Pharma's investors include Bpifrance, Crédit Agricole, UI Investissement, Eurostars, Noshaq.
Brenus Pharma is headquartered in Issoire, France.
Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance.
Brenus Pharma is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Brenus Pharma — Funding & Investors." VCBacked, July 20, 2026, https://www.vcbacked.co/company/brenus-pharma. Accessed September 5, 2026.
VCBacked. (2026). Brenus Pharma — Funding & Investors. Retrieved September 5, 2026, from https://www.vcbacked.co/company/brenus-pharma
{{cite web |title=Brenus Pharma — Funding & Investors |url=https://www.vcbacked.co/company/brenus-pharma |website=VCBacked |access-date=September 5, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated